Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S. 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
CLEVELAND, Nov. 07, 2016 -- Chart Industries, Inc. (Nasdaq:GTLS), a leading diversified global manufacturer of highly engineered equipment for the industrial gas, energy and biomedical industries, today announced an organizational realignment within its BioMedical Group to better position the company to capture future growth in the respiratory products industry.
The Group will realign a portion of its manufacturing and engineering operations and establish a Respiratory Center-of-Excellence in Canton, GA where engineering, manufacturing, sales and marketing will be centralized to jointly develop and deliver industry leading respiratory products. To realize this change, the company expects to consolidate a majority of its U.S. respiratory operation and engineering activities into the existing Canton, GA campus, relocate key personnel, and suspend production and engineering of respiratory products at its Amherst, NY facility.
“This transformation enables the company to improve collaboration and infrastructure utilization to drive product innovation, efficiency, speed, and quality,” said Earl Lawson, President of Chart BioMedical. “This realignment and our continued investment in respiratory solutions demonstrates our commitment to the industry and to improving the quality of life for millions of people suffering from COPD and other lung diseases. We are positioning the company to meet our strategic goal to have associated core engineering, manufacturing, sales and marketing resources located together to better support the growing demand for our products.”
Chart is a leading diversified global manufacturer of highly engineered equipment for the industrial gas, energy, and biomedical industries. The majority of Chart's products are used throughout the liquid gas supply chain for purification, liquefaction, distribution, storage and end-use applications. Chart has domestic operations located across the United States and an international presence in Asia, Australia, Europe and South America. For more information, visit: http://www.chartindustries.com.
Contact: Ken Webster Vice President and Chief Financial Officer 216-626-1216 [email protected]
